.png)
3rd GLOBAL WEBINAR ON
Virology & Vaccine Development [COVID 19]
Nov 24 - 25, 2021 (Greenwich Mean Time - London Time)
About Conference
Innovinc International and the organizing committee of Virology Webinar is organizing the 3rd Global webinar on Virology and Vaccine Development [Covid 19] on November 24-15, 2021 (Greenwich Mean Time – London Time) runs through the ZOOM platform. The main objective of Virology Webinar 2021 is to promote basic and applied virology both amongst interested parties and society as a whole, to encourage the exchange of information, and stimulate discussion and collaboration among virologists.
Infectious disease research leads to the development of critical solutions to address past, present, and future infectious outbreaks— from revealing the mechanism of host-pathogen effects and innate immune response, to more applied translational research on vaccine development and immune system function and autoimmune disease. The program encompasses a wide range of topics, from vaccine research, an immune response to viral infections, diagnostics, and the use of artificial intelligence to contain the spread of the virus, to clinically orientated lectures on the emerging treatment options and novel insights into disease pathophysiology.
This discussion will bring together a unique panel of experts in viral evolution, vaccines, immunology, virology, infectious disease, and infection control to answer questions about virus evolution and its impact on the future of the pandemic as well as live panel discussion is an opportunity for you to learn about vaccine development from all experts. Moreover, you can get all your questions answered.
What physicians need to know about vaccine development
- Health care leaders address questions about the COVID-19 vaccine
- Therapeutic Approaches in Targetting COVID-19 Pandemic: Drug Repurposing and Vaccination
- Drug Discovery & Development
Target Audience:
Epidemiologist | Immunologists | Infectious disease clinicians | Clinical virologists | Primary care physicians | Intensivists | Microbiologists | Health care providers | Specialized nurses
For further information, please contact conference Organizer Dr.Julie Picard: Juliepicard@innovinc.org Tel: +1-408-352-1010
Scientific Sessions
- Covid-19
- COVID Vaccines
- Vaccine Distribution
- Vaccine Development and Efficacy Evaluation
- Emerging Diseases (Chik, Zika, Dengue, Ebola, Nipah)
- Immune Responses to Vaccines
- Vaccine Vectors, Adjuvants and Immunomodulators
- Veterinary Vaccinology
- Vaccines against Neurological Infections
- Influenza Vaccines Fungal/Bacterial/ AMR Vaccines
- Age Based v Risk Based Vaccination
- Spirochetal Diseases Vaccine Durability (Measles/Mumps/Pertussis)
- Systems Vaccinology and Big Data and AI
- STD Vaccines
- Future of Vaccines and Biotherapeutics Development
- Regulatory affairs, commercial utilization, Policy and safety
- Vaccines in Bioterrorism
- Basics of Viral diagnostics
- Understanding viral infections and SARS-CoV-2
- Updates on research into Covid19 treatment strategies
- Updates of Hanta Virus infection
- Pharmacological management of Covid19 infection
- Personal Protection and Infection Prevention
speakers
Bahareh Sahebi
Northwestern University, USA
Jacques Simkins
University of Miami School of Medicine, USA
Alejandro García Irigoyen
Hospital General "Dr. Manuel Gea González, Mexico
Raphael Stricker
Union Square Medical Associates, USA
FRANCISCO GOVEDIC
SANATORIO ALLENDE OF CORDOBA, Argentina
Ajoy Tiwari
Jai Clinic & Diabetes Care Center, India
Vijayashree
Narayana Health, India
Emanuel Gluskin
Puppin Academic Center, Israel
Pedram Keshavarz
The University of Georgia, Tbilisi, Georgia , Georgia
Mamtha Balla
University of Toledo Health sciences, United States
Azizullah Beran
University of Toledo, USA
Jie Yang
The first affiliated hospital of chengdu medical college, China
Refael Minnes
Ariel University, Israel
Mina Kelleni
Minia University College of Medicine, Egypt
Oscar Millet
CIC biogune, Spain
BIBI NORAINI MOHD YUSUF
Universiti Malaysia Perlis, Malaysia
Anil Kumar Kruthiventi
Arna Immuno Ingredients Private Limited, India
HURRY UP! ONLY 120 SEATS REMAINING CURRENTLY…
Don t Miss This Amazing Conference And Opportunities
Testimonials
Denis Rodrigue
Université Laval, CanadaThank you very much for the invitation and the Innovinc International Conferences.Everything went very well. I congratulate the whole team for the success of Webinar
Roy Shenhar
I think all of them have been high quality talks. There is an opportunity to interact with people personally and to establish and expand collaborations and get to know each other. So it is an excellent setup and I will encourage to keep doing these